IL6 and neuroblastoma: Since the suppression of NK cell activation by neuroblastoma/monocyte CM was likely due to IL-6 [5] and/or TGFβ1 [7], we next tested these cytokines alone and with lenalidomide to determine the effects upon NK cell activation.